23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

第23届艾滋病毒合并症和药物不良反应年度国际研讨会

• 批准号: 10327072
• 负责人: TODD T BROWN
• 金额: $ 4.3万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-20 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10327072
• 关键词: Acquired Immunodeficiency Syndrome; Adolescent; Adverse effects; Age; Area; COVID-19; COVID-19 pandemic; Cardiovascular Diseases; Cause of Death; Child; Chronic; Chronic Disease; Clinical; Clinical Management; Collaborations; Communicable Diseases; Communities; Disease; Educational workshop; Elements; England; Etiology; Europe; European; Event; Feedback; Fostering; Goals; HIV; Home; Inflammation; International; International AIDS; Liver diseases; London; Longevity; Opportunistic Infections; Oral; Pathogenesis; Persons; Play; Program Development; Psychiatrist; Research; Research Personnel; Retroviridae Infections; Risk Factors; Role; Schedule; Scholarship; Societies; South Africa; Specialist; Stroke; Training Programs; Translational Research; Travel; Ursidae Family; Work; adverse drug reaction; antiretroviral therapy; career; career development; clinical practice; co-infection; comorbidity; disability; healthspan; improved; low and middle-income countries; meetings; non-alcoholic fatty liver disease; pediatric cardiologist; peer; posters; programs; research clinical testing; success; symposium; virtual

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including low and middle income countries (LMIC). Large meetings, such as the Conference for Retroviruses and Opportunistic Infections and the International AIDS Society Conference, are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats,that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. The International Workshop for Comorbidities and Adverse Drug Reactions in HIV, now in its 23rd year, provides <200 delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity research in one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. Abstract presentations including 24 15- minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 23rd Workshop (October 25th/26th in London) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to support early-stage investigators with a scholarship program and a Career Development Studio, and guided poster tour, 3) to increase the impact of the Workshop through the webcast of plenary and abstract presentations. By providing a “scientific home” to an increasing number of HIV Comorbidity investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH.

随着抗逆转录病毒疗法（ART）的成功，合并症现已成为主要原因